Suppr超能文献

泰国的血管免疫母细胞性淋巴结病伴蛋白异常血症

Angioimmunoblastic lymphadenopathy with dysproteinemia in Thailand.

作者信息

Jootar S, Nitiyanant P, Ratanaprakarn S

机构信息

Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand.

出版信息

Asian Pac J Allergy Immunol. 1987 Dec;5(2):119-23.

PMID:3329519
Abstract

Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is a disease of unknown etiology and pathogenesis. It has the features of hyperimmunity and immune deficiency, and its behavior resembles malignant lymphoma. We report a review of 16 patients with AILD seen at Ramathibodi Hospital from 1982 to 1986. Thirteen patients had fever and seven had pruritus and rashes. Lymphadenopathy was found in all 16 cases; generalized in 14 and localized in 2. Hepatomegaly was present in 14 patients while only 7 had splenomegaly. Laboratory findings included autoimmune hemolytic anemia, lymphocytosis and polyclonal hypergammaglobulinemia. Pulmonary involvement was seen in 5 cases, and bone marrow showed the characteristic features of the disease in 9 cases. Two patients went on to develop diffuse lymphocytic, poorly differentiated lymphoma. Fourteen patients were treated with prednisolone initially. Five responded with complete recovery, eight responded with partial recovery, and one died with extensive involvement of the disease. Six of the patients that recovered partially were later treated with cyclophosphamide, vincristine and prednisolone. One patient recovered completely and two partially. Three died from extensive involvement. Two patients with malignant lymphoma were treated by combination chemotherapy. One case went to complete remission while the other died from infection. One patient was lost to follow up before any treatment was started.

摘要

血管免疫母细胞性淋巴结病伴蛋白异常血症(AILD)是一种病因和发病机制不明的疾病。它具有免疫亢进和免疫缺陷的特征,其行为类似于恶性淋巴瘤。我们报告了1982年至1986年在拉玛蒂博迪医院诊治的16例AILD患者的回顾性研究。13例患者有发热,7例有瘙痒和皮疹。16例均有淋巴结病;14例为全身性,2例为局限性。14例患者有肝肿大,而仅有7例有脾肿大。实验室检查结果包括自身免疫性溶血性贫血、淋巴细胞增多和多克隆高球蛋白血症。5例有肺部受累,9例骨髓显示出该病的特征性表现。2例患者后来发展为弥漫性淋巴细胞性、低分化淋巴瘤。14例患者最初用泼尼松龙治疗。5例完全康复,8例部分康复,1例因疾病广泛累及死亡。6例部分康复的患者后来用环磷酰胺、长春新碱和泼尼松龙治疗。1例完全康复,2例部分康复。3例因疾病广泛累及死亡。2例恶性淋巴瘤患者接受联合化疗。1例完全缓解,另1例死于感染。1例患者在开始任何治疗前失访。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验